{"id":621,"date":"2026-03-10T01:36:50","date_gmt":"2026-03-10T01:36:50","guid":{"rendered":"https:\/\/euro-dmcrn.org\/2026\/?page_id=621"},"modified":"2026-03-12T15:59:19","modified_gmt":"2026-03-12T15:59:19","slug":"page-avidity","status":"publish","type":"page","link":"https:\/\/euro-dmcrn.org\/2026\/?page_id=621","title":{"rendered":"Page Avidity"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"621\" class=\"elementor elementor-621\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2d2444b e-con-full e-flex e-con e-parent\" data-id=\"2d2444b\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7a5e4e0 elementor-widget elementor-widget-heading\" data-id=\"7a5e4e0\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Industry Partner<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-706cd42 e-flex e-con-boxed e-con e-parent\" data-id=\"706cd42\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-83183e5 elementor-widget elementor-widget-image\" data-id=\"83183e5\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/www.aviditybiosciences.com\/\">\n\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"768\" height=\"361\" src=\"https:\/\/euro-dmcrn.org\/2026\/wp-content\/uploads\/2026\/03\/Avidity-Logo_FullColour_CMYK-1-768x361.png\" class=\"attachment-medium_large size-medium_large wp-image-547\" alt=\"\" srcset=\"https:\/\/euro-dmcrn.org\/2026\/wp-content\/uploads\/2026\/03\/Avidity-Logo_FullColour_CMYK-1-768x361.png 768w, https:\/\/euro-dmcrn.org\/2026\/wp-content\/uploads\/2026\/03\/Avidity-Logo_FullColour_CMYK-1-300x141.png 300w, https:\/\/euro-dmcrn.org\/2026\/wp-content\/uploads\/2026\/03\/Avidity-Logo_FullColour_CMYK-1-1024x482.png 1024w, https:\/\/euro-dmcrn.org\/2026\/wp-content\/uploads\/2026\/03\/Avidity-Logo_FullColour_CMYK-1-1536x723.png 1536w, https:\/\/euro-dmcrn.org\/2026\/wp-content\/uploads\/2026\/03\/Avidity-Logo_FullColour_CMYK-1-2048x964.png 2048w\" sizes=\"(max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-4b828b0 e-con-full e-flex e-con e-child\" data-id=\"4b828b0\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6a2ce7b elementor-widget elementor-widget-text-editor\" data-id=\"6a2ce7b\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><span lang=\"EN-US\">Avidity Biosciences Inc., a wholly owned subsidiary of Novartis, is developing novel RNA therapeutics. Its platform enables targeted RNA delivery by combining antibody specificity with oligonucleotide precision, addressing disease mechanisms at their source. This approach allows access to tissues previously unreachable by other RNA therapies, advancing precision medicine across rare therapeutic areas<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t <script type=\"text\/javascript\"> if (typeof(f_tFlgVISA) === typeof(Function))  \tf_tFlgVISA(null);  if (typeof(f_tFlgAllergia) === typeof(Function))  \tf_tFlgAllergia(null);  if (typeof(f_IDTipologia) === typeof(Function)) {  \tvar eObjTYPE = document.getElementById(\"id_IDTipologia\");  \tf_IDTipologia(eObjTYPE);  }  if (typeof(f_IDAttivita) === typeof(Function)) {  \tvar etFlgActivity = document.getElementById(\"id_IDAttivita\");  \tf_IDAttivita(etFlgActivity);  }  if (typeof(f_IDNazionalita) === typeof(Function)) {  \tvar etFlgNazionalita = document.getElementById(\"id_IDNazionalita\");  \tf_IDNazionalita(etFlgNazionalita);  }  if (typeof(f_IndFattIDNazione) === typeof(Function))  \tf_IndFattIDNazione(null);  <\/script>","protected":false},"excerpt":{"rendered":"<p>Industry Partner Avidity Biosciences Inc., a wholly owned subsidiary of Novartis, is developing novel RNA therapeutics. Its platform enables targeted RNA delivery by combining antibody specificity with oligonucleotide precision, addressing disease mechanisms at their source. This approach allows access to tissues previously unreachable by other RNA therapies, advancing precision medicine across rare therapeutic areas<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-621","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/euro-dmcrn.org\/2026\/index.php?rest_route=\/wp\/v2\/pages\/621","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/euro-dmcrn.org\/2026\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/euro-dmcrn.org\/2026\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/euro-dmcrn.org\/2026\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/euro-dmcrn.org\/2026\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=621"}],"version-history":[{"count":7,"href":"https:\/\/euro-dmcrn.org\/2026\/index.php?rest_route=\/wp\/v2\/pages\/621\/revisions"}],"predecessor-version":[{"id":673,"href":"https:\/\/euro-dmcrn.org\/2026\/index.php?rest_route=\/wp\/v2\/pages\/621\/revisions\/673"}],"wp:attachment":[{"href":"https:\/\/euro-dmcrn.org\/2026\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=621"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}